Invention Grant
- Patent Title: Derivatives of gefitinib
- Patent Title (中): 吉非替尼的衍生物
-
Application No.: US12358238Application Date: 2009-01-22
-
Publication No.: US07855204B2Publication Date: 2010-12-21
- Inventor: Roger Tung
- Applicant: Roger Tung
- Applicant Address: US MA Lexington
- Assignee: Concert Pharmaceuticals Inc.
- Current Assignee: Concert Pharmaceuticals Inc.
- Current Assignee Address: US MA Lexington
- Agency: Edwards Angell Palmer & Dodge LLP
- Agent Jeffrey D. Hsi; Mark D. Russett
- Main IPC: C07D413/12
- IPC: C07D413/12 ; A61K31/5377
Abstract:
This invention relates to novel quinazoline derivatives, their derivatives, pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by inhibiting cell surface tyrosine receptor kinases.
Public/Granted literature
- US20090185999A1 DERIVATIVES OF GEFITINIB Public/Granted day:2009-07-23
Information query
